PROM1 and osteosarcoma: CD133 aptamers-functionalized polymeric nanoparticles could specifically and efficiently deliver anticancer drugs to CD133 positive osteosarcoma CSCs, and significantly improve therapeutic effects than free drugs and non-targeted nanoparticles 32, 114.